Please login or create an account. If you do not have access to this content, you will be shown a 30 second preview and licensing options.
- Presentation
Pediatric Allergic Contact Dermatitis: Patch Testing, Atopic Dermatitis, and Common Allergens
Description
The talk reviews pediatric allergic contact dermatitis (ACD), emphasizing that it is likely underrecognized and under-tested in children, despite patch test positivity rates being similar to adults. The speaker explains that atopic dermatitis (AD) and ACD commonly overlap rather than being mutually exclusive, and children with AD—especially more severe or recalcitrant disease—may actually be more prone to developing ACD because of impaired skin barrier function and greater exposure to topical products. Patch testing should be considered for children with eczema that is treatment-resistant, appears in unusual locations, changes unexpectedly, or begins later in childhood. The speaker compares patch test options, noting that more comprehensive allergen series detect more relevant allergens than smaller panels, and describes practical approaches for patch testing children, including using the back, thighs, or testing directly with the child’s own products and materials. He also addresses testing while on therapies such as dupilumab, suggesting it can often be done without stopping treatment, though data for newer systemic agents in younger children are limited. Examples illustrate how patch testing can identify culprits such as propylene glycol, crisaborole, bacitracin, cocamidopropyl betaine, fragrances, metals, and preservatives, leading to meaningful improvement when allergens are avoided. Overall, the speaker concludes that patch testing is an important tool in pediatric eczema care and can reveal a significant ACD component even when AD is also present.
View moreConclusions
- Allergic contact dermatitis appears to be common in children and is likely under-recognized because kids are referred for patch testing far less often than adults.
- Children who are evaluated for patch testing have positive reaction rates that are similar to adults, so pediatric contact dermatitis should be taken seriously rather than assumed to be only atopic dermatitis.
- Atopic dermatitis and allergic contact dermatitis frequently overlap, and children with worse or more extensive AD are at increased risk of also having ACD.
- Patch testing is most useful in children with recalcitrant eczema, unusual distribution, sudden worsening, or new-onset eczema in older children.
- Using larger or more comprehensive allergen series improves detection of relevant allergens, but the choice of series must be balanced against the child’s available skin surface.
- Patch testing can be done safely in children, including many children receiving dupilumab, and testing should often proceed without stopping that therapy.
- Avoiding identified allergens can meaningfully improve many children’s eczema, sometimes completely, showing that a substantial portion of their dermatitis may be due to ACD rather than AD alone.
- Common pediatric allergens include metals, fragrances, preservatives, topical medications, and surfactants, which are often found in everyday products and treatments used on children.
- The session’s overall message is that clinicians should have a lower threshold to suspect and evaluate allergic contact dermatitis in children with eczema.
- Malajian D, Belsito DV. Journal of the American Academy of Dermatology. 2013.
- Contact sensitization in children and adolescents: Trends from a multicentre European study (2011–2022).#10.1111/pai.70245/v3/review2
- Prevalence of allergic contact dermatitis in children with and without atopic dermatitis: A multicenter retrospective case-control study.#10.1016/j.jaad.2023.06.048
- The Impact of Systemic Immunomodulating Therapies on Patch Testing Results in Children: A Retrospective Cohort Study.#10.1089/derm.2023.0414
- TABLE 2. Pediatric Baseline Series.
- TABLE 1. Relative rates of common pediatric allergen inclusion by patch series.